Life Sciences Report Collection
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global...
The global market for nebulizers, inhalers and respirators has reached nearly $11.2 billion and $12.4 billion in 2013 and 2014, respectively. This market is expected to grow at compound annual growth rate (CAGR) of 8.9% to reach $19.0 billion in 2019.
Diagnostics and Therapeutics for Autism Spectrum Disorders: Globa...
The global autism spectrum disorders (ASD) market was valued at $346.2 million in 2013 and $360.9 million in 2014. This market is expected to grow to $412.7 million by 2019, a compound annual growth rate (CAGR) of 2.7%.
Stroke Diagnostics and Therapeutics: Global Markets
The global stroke management market was valued at $19.2 billion in 2013 and nearly $20.2 billion in 2014. This market is expected to reach nearly $28.3 billion by 2019, with a compound annual growth rate (CAGR) of 7% from 2014 to 2019.
Cardiac Equipment: Technologies and Global Markets
The global market for cardiac medical devices was valued at nearly $49.4 billion in 2013 and $52 billion in 2014. This market is projected to reach nearly $67.5 billion by 2019, with a compound annual growth rate (CAGR) of 5.3% from 2014 to 2019.
Incretin-Based Drugs: Markets for Diabetes Therapies and Developi...
The global market for incretin-based therapeutics was valued at nearly $11.8 billion in 2013 and $12.7 billion in 2014. This market is expected to reach $22.8 billion by 2019, with a compound annual growth rate (CAGR) of 12.4% from 2014 to 2019.
Therapeutics for 'Silent' Cancers
The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual growth rate (CAGR) of 8.5% from 2014 to 2019.
Global Markets for Implantable Biomaterials
The global market for implantable biomaterials in 2013 was worth nearly $75.1 billion. This market is expected to grow at a compound annual growth rate (CAGR) of 6.7% between 2014 and 2019. This will result in $79.1 billion in 2014 and $109.5 billion global market in 2019.
U.S. and Global Markets for Ethical Nutrition in Healthcare
The global market for ethical nutrition in healthcare was valued at roughly $34.5 billion in 2013 and increased to $37.1 billion in 2014. This market is expected to reach about $58.2 billion by 2019, with a compound annual growth rate (CAGR) of 9.4% from 2014 to 2019.
Enteric Disease Testing and Treatment: Technologies and Global Ma...
The global market for diagnostics and preventive vaccines for enteric diseases reached $6.5 billion in 2013. This market should grow to $10 billion in 2014 and about $21.9 billion in 2018, a compound annual growth rate (CAGR) of 27.3%.
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Ma...
The global market for nucleic acid aptamers reached $340.5 million in 2014. This market should grow to about $610.3 million in 2015 and about $5.4 billion in 2019, with a compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.
Global Markets for Nanoparticle Size Analysis Instrumentation in ...
The global market for nanoparticles instrumentation in life sciences was $5.6 billion in 2013. This value is expected to increase to $5.9 billion in 2014 and about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Glo...
The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.
Blood-Brain Barrier Technologies and Global Markets
The global market for blood-brain barrier (BBB) technology for therapeutics reached $21.8 million in 2013. This market is expected to grow from $38.7 million in 2014 to $471.5 million in 2019, a compound annual growth rate (CAGR) of 64.9% from 2014 through 2019.
Joint Reconstruction and Replacement: Materials, Technologies, an...
The global market for joint reconstruction and replacement was worth nearly $13.2 billion in 2013. This market is expected to increase to nearly $16.2 billion by 2018, registering a compound annual growth rate (CAGR) of 4.2% from 2013 through 2018.
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Glo...
The global market for Multiple Sclerosis (MS) disease-modifying products reached $10.1 billion in 2012 and nearly $10.9 billion in 2013. This market is expected to grow to nearly $14.2 billion in 2018 with a compound annual growth rate (CAGR) of 5.4% over the five-year period from 2013 to 2018.
JAK and PI3K Signaling Pathway Markets
The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.
Drugs for Treating Systemic Lupus Erythematosus: Global Markets
The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.
Peripheral Vascular Surgical Products: Technologies and Global Ma...
The global market for peripheral vascular surgical devices reached $5.8 billion in 2012. This market is projected to grow from $6.2 billion in 2013 to $8.4 billion in 2018 with a compound annual growth rate (CAGR) of 6.3% for the five-year period, 2013 to 2018.
Histone Deacetylase Inhibitors: Emerging Markets
The global histone deacetylase inhibitor (HDI) market reached $153 million in 2011 and $223.2 million in 2012. This market is expected to be valued at $361.8 million in 2013 and $954.3 million by 2018, a compound annual growth rate (CAGR) of 21.4%.
Drugs for Treating Mental Disorders: Technologies and Global Mark...
The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach nearly $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
Global Markets and Technologies for Advanced Drug Delivery System...
The global revenue for advanced drug delivery systems is estimated to be $181.9 billion in 2013. In 2018, revenues are estimated to reach $212.8 billion, demonstrating a compound annual growth rate (CAGR) of 3.2%.
2013 Oncology Research Review
This BCC Research review provides highlights from oncology and other related market research reports published in 2013. It covers topics like uterine cancer, ovarian cancer, cervical cancer, prostrate cancer, and hematological disorders.
Global Markets and Technologies for Molecular Imaging Devices
The global market for molecular imaging devices was valued at $2 billion in 2012. This market is expected to reach $2.2 billion in 2013 and nearly $3 billion by 2018, with a compound annual growth rate (CAGR) of 6.2% for the period of 2013 to 2018.
